McGraw Hill Q2 revenue falls 5.5% as K-12 declines

By Reuters News


Overview

  • US education solutions provider's fiscal Q2 revenue fell 5.5% yr/yr, but topped company expectations

  • Adjusted EBITDA margin fell to 39.6% from 42.8%

  • Digital revenue rose 2.6% yr/yr, supported by AI tool adoption and platform growth


Outlook

  • McGraw Hill reaffirms FY 2027 revenue guidance of $2.115 bln to $2.175 bln

  • Company maintains FY 2027 re-occurring revenue outlook of $1.587 bln to $1.627 bln

  • McGraw Hill expects FY 2027 adjusted EBITDA between $750 mln and $790 mln


Result Drivers

  • DIGITAL REVENUE GROWTH - Co said digital revenue rose 2.6% yr/yr, driven by strong retention, learning platform adoption and increased AI tool usage

  • HIGHER EDUCATION MARKET SHARE - Co said Higher Education segment revenue grew 0.2% yr/yr, citing continued market share gains and value-based pricing momentum

  • K-12 MATH WEAKNESS - Co said K-12 segment revenue fell 9.6% yr/yr, as strength in Science and ELA was offset by lower anticipated capture rates in select Math markets


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

$632.21 mln

Q2 EPS

$0.45

Q2 Adjusted Net Income

$144.56 mln

Q2 Net Income

$86.38 mln

Q2 Adjusted EBITDA

$250.62 mln

Q2 Adjusted EBITDA Margin

39.60%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the consumer publishing peer group is "buy"

  • Wall Street's median 12-month price target for McGraw Hill, Inc. is $17.00, about 33.2% above its November 4 closing price of $12.76

  • The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 6 three months ago


Reuters Recommended Reads

  • Nov 4 - HMH Holding Q3 revenue falls on lower volume across product

  • Nov 5 - Strategic Education Q3 revenue rises 1.6%, slightly misses estimates

  • Nov 4 - Charles River Laboratories Q3 revenue beats estimates, lifts 2026 outlook


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk